期刊文献+

微阵列芯片分析人胶质瘤miRNA差异表达谱 被引量:1

The differentially expressed miRNA in human glioblastoma based Microarray
原文传递
导出
摘要 目的检测人胶质瘤与非肿瘤脑组织中微小RNA(miRNA)的表达差异情况。方法选取经手术切除的胶质瘤组织标本及非肿瘤脑组织,分别提取总RNA和小分子RNA,在miRNA微阵列芯片中杂交检测,通过芯片扫描和数据聚类分析,并通过实时荧光定量RT-PCR验证,获得该病异常miRNAs表达谱。结果筛选出5个胶质瘤的相关miRNAs,其中表达上调2个,表达下调3个。其中上调的有miR-18b、miR-486;下调的有miR-237、miR-96、miR-21,差异表达情况得到定量RT-PCR的证实。结论筛选出的差异表达miRNAs可能参与胶质瘤的发生发展。 Objective To explore the differentially expressed microRNAs in glioblastoma and to the relationship between pathogenesis using miRNA microarray.Methods The tumor tissue glioblastoma and non-tumors tissue were obtained from undergoing surgical resection.Total RNA,including the small RNAs,was extracted and isolated respectively.Hybridization was carried out on miRNA microarray chip.Real-time quantitative RT-PCR was performed to confirm results obtained by microarray analysis.Results Five miRNAs have been identified,2 of them were up-regulated and the remaining three were down-regulated in cancer tissues.The differential expression of miR-18b、miR-486、miR-237、miR-96、miR-21 was confirmed by microarray analysis.Conclusion The differentially expressed microRNAs miRNA genes in this study may be involved in the pathogenesis of human glioblastoma.
作者 杨立坚 彭健
出处 《中国误诊学杂志》 CAS 2010年第20期4789-4792,4804,共5页 Chinese Journal of Misdiagnostics
关键词 微阵列分析 神经胶质瘤/代谢 微RNAs/代谢 Microarray Analysis Glioma/metabolism MicroRNAs/metabolism
  • 相关文献

参考文献10

  • 1Yamamoto T, Naakai K, Matsumura A. Boron neutron capture therapy for glioblastoma[J]. Cancer Lett, 2008, 262(2):143- 152.
  • 2Brandsma D, Stalpers L, Taal W, et al. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas[J]. Lancet Oncol, 2008, 9(5):453-461.
  • 3Ren H, Yang BF, Rainov NG. Receptor tyrosine kinases as therapeutic targets in malignant glioma[J]. Rev Recent Clin Trials, 2007, 2(2) :87-101.
  • 4Everson RG, Graner MW, Gromeier M, et al. Immunotherapy against angiogenesis associated targets: evidence and implications for the treatment of malignant glioma[J]. Expert Rev Anticancer Ther, 2008, 8(5):717-732.
  • 5Sarkaria JN, Kitange GJ, James CD, et al. Mechanisms of chemoresistance to alkylating agents in malignant glioma[J]. Clin Cancer Res,2008,14(10) :2900-2908.
  • 6Mizoguchi M, Shono T. Molecular genetic analysis for malignant gliomas: clinical implications and future directions[J]. No Shinkei Geka, 2008, 36(1) :83-91.
  • 7Mathupala SP, Guthikonda M, Sloan AE. RNAi based approaches to the treatment of malignant glioma[J]. Technol Cancer Res Treat, 2006, 5(3):261-269.
  • 8Benard J, Douc-Rasy S. MicroRNA and oncogenesis [J]. Bull Cancer, 2005, 92(9) :757-762.
  • 9Ciafre SA, Galardi S, Mangiola A, et al. Extensive modulation of a set of micro RNAs in primary glioblastoma[J]. Bioehem Biophys Res Commun, 2005, 334(4):1351-1358.
  • 10Chan JA, Krichevsky AM, Kosik KS. MicroRNA 21 is an antiapoptotic factor in human glioblastoma cells[J]. Cancer Res, 2005, 65(14) :6029-6033.

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部